premature and severe defects in synaptic plasticity, behavior and cognitive function. These data provide a mechanism underlying leaky RyR2 channels, which could be considered as potential AD therapeutic targets.
Introduction
Alzheimer's disease (AD) is characterized by an overload of toxic amyloid beta (Aβ) peptides in the brain associated with premature onset of cognitive dysfunction. Modulation of Aβ peptide production is a consistent finding in a subset of autosomal-dominant familial AD cases (FAD) due to mutations of β amyloid precursor protein (βAPP) or γ-secretase/presenilins (PS1 or PS2).
A "calcium (Ca 2+ ) hypothesis" of AD has been proposed, whereby βAPP and PS1/2 mutations have been linked to alterations in Ca 2+ handling [10, 20, 78] that disrupt key mechanisms involved in learning and memory [6] . Increased cytosolic [Ca 2+ ] has been Abstract The mechanisms underlying ryanodine receptor (RyR) dysfunction associated with Alzheimer disease (AD) are still not well understood. Here, we show that neuronal RyR2 channels undergo post-translational remodeling (PKA phosphorylation, oxidation, and nitrosylation) in brains of AD patients, and in two murine models of AD (3 × Tg-AD, APP +/− /PS1 +/− ). RyR2 is depleted of calstabin2 (KFBP12.6) in the channel complex, resulting in endoplasmic reticular (ER) calcium (Ca 2+ ) leak. RyRmediated ER Ca 2+ leak activates Ca
2+
-dependent signaling pathways, contributing to AD pathogenesis. Pharmacological (using a novel RyR stabilizing drug Rycal) or genetic rescue of the RyR2-mediated intracellular Ca 1 3
proposed to involve both enhanced Ca 2+ entry via receptor-operated channels on the plasma membrane (e.g., NMDARs) [81] and increased release of Ca 2+ from the endoplasmic reticulum (ER) via ryanodine receptors (RyR) that regulate ER Ca 2+ release [28] and inositol 1,4,5-trisphosphate receptors (IP 3 R) [13, 15, 20, 65, 74] . RyR dysfunction has been reported in AD animal models [11, 58, 63] . However, the molecular mechanisms underlying RyR dysfunction in AD remain poorly understood.
RyRs are a family of three known mammalian isoforms: RyR1, RyR2 and RyR3, which are classified as "skeletal muscle", "heart" and "brain" types. Although all isoforms can be found in the brain, the RyR2 isoform is predominantly expressed in the cerebral cortex and dentate gyrus of the hippocampus [32] . RyRs are homotetramers in which each protomer of the channel has a molecular mass of 565 kDa, with 4/5 of the channel comprising a huge N-terminal cytoplasmic domain that serves as a scaffold for channel regulators, while the remainder of the channel forms the pore and associated transmembrane portions [70] .
Enhanced RyR-mediated ER Ca 2+ leak is linked to pathophysiological post-translational modifications in the macromolecular complex [48] . Here, we show that neuronal RyR2 channels undergo post-translational remodeling characterized by PKA phosphorylation, oxidation/nitrosylation and depletion of the channel stabilizing subunit calstabin2 (FKBP12.6) in human sporadic AD, APP +/− /PS1 +/− (APP-K670N/ M671L, PS1-M146V) and 3 × Tg-AD (Tau-P301L, APP-K670N/M671L, PS1-M146V) transgenic mice. RyR2 channel remodeling results in an ER Ca 2+ leak that activates Ca 2+ -dependent signaling pathways which are altered in AD. Fixing the leaky RyR2 channels with an oral administration of Rycal S107, which prevents stress-induced dissociation of calstabin2 from the RyR2 complex [85] , inhibited calpain activity and AMPKdependent tau phosphorylation, improved hippocampal synaptic plasticity (LTP and LTD) and cognitive function, and diminished neuropathology (reduced plaques) in the APP +/− /PS1 +/− and 3 × Tg-AD brains. Moreover, crossing APP +/− /PS1 +/− mice with RyR2-S2808A
knock-in mice, harboring RyR2 channels that cannot be PKA phosphorylated, resulted in improved cognitive function and decreased neuropathology. In contrast, mice harboring constitutively leaky PKA phosphomimetic RyR2-S2808D +/+ channels exhibited early cognitive and synaptic dysfunction.
Taken together, our data show that remodeling of the RyR2 macromolecular complex may contribute to altered βAPP metabolism and AD pathogenesis.
Materials and methods

In vivo animal models
We used male and female C57BL/6-SJLF1-APP
C57BL/6-D2F1-PS1
+/− double transgenic mice that express two human FAD mutations, presenilin 1 (PS1-M146V) [22] 
/PS1
+/− crossed mice. We also used female 3 × Tg-AD mice obtained by pronuclear microinjection of two independent transgene constructs encoding human APPswe and tau-P301L (4R/0N), both under the control of the mouse Thy1.2-regulatory elements, into single-cell embryos harvested from mutant homozygous (PS1-M146V) knock-in mice [57] . We used male and female WT littermate controls C57BL/6-SJLF1 for the APP +/− mice, C57BL/6-D2F1 for the PS1 PS1 +/− mice, C57BL/6 for the RyR2-S2808A mice, RyR2-S2808A mice, and RyR2-S2808A
+/− as well, and females 129/C57BL6 for 3 × Tg-AD mice. All animal models were housed in the SPF animal facility. S107 (75 mg/kg/day) was delivered to the mice in the drinking water to APP
+/− from 4 weeks of age until testing at 3 months of age, or until 5 months. We used 6-month-old APP
+/− mice for neuropathology examinations, including plaques and gliosis analyses. 11-month-old 3 × Tg-AD mice were treated orally for 4 weeks with S107. "S2808D +/++ mice were treated orally with S107 in the drinking water from 4 weeks until testing at 2 months (F0), or continuously for two generations (F2) and were tested at 2 months. S107 was also used in previous studies [3, 5, 54] and was administered subcutaneously by implanting osmotic pumps or mixed in drinking water. These studies did not reveal any toxicity related to S107 treatment. Investigators were blinded with respect to genotypes and treatments.
For biochemical analyses, mice were euthanized by cervical dislocation prior to dissection and brain isolation. The Isolated brains were snap-frozen in liquid nitrogen. For immunohistochemistry analyses, mice were anesthetized with a ketamine/xylazine mixture and cardiac perfusion was then applied with PBS for 5 min and then with 10 ml PFA 4% solution. Brains were post-fixed in PFA 4% for 24 h.
Human samples
Human brain samples were provided by the Department of Pathology, Columbia University College of Physician and Surgeons. Cases were de-identified, but information was provided regarding age at death and neuropathology (see supplementary Table I ). Brain samples were stored at −80 °C. Approximately, 1 g of tissue was homogenized in 10 ml of 10 mM Tris-maleate buffer containing protease and phosphatase inhibitors (Roche diagnostics). The homogenates were centrifuged at 10,000×g and the supernatants collected.
Biochemistry measurements for RyR2 channel remodeling
The isolation of mouse brain microsomes has been described previously [48, 52] . Briefly, mouse and human RyR2 were immunoprecipitated from the brain lysate with an RyR2 specific antibody (2 μg) in 0.5 ml of a modified RIPA buffer (50 mM Tris-HCl pH 7.2, 0.9%NaCl, 5.0 mM NaF, 1.0 mM Na3VO4, 1%Triton-X100, and protease inhibitors) and left overnight at 4 °C. The RyR2 specific antibody is an affinity-purified polyclonal rabbit antibody, custom-made by Yenzym Antibodies (San Francisco, CA) using the peptide CKPEFNNHKDYAQEK corresponding to amino acids 1367-1380 of mouse RyR2 with a cysteine residue added to the amino terminus. This antibody recognizes both human and mouse RyR2. The immune complexes were incubated with protein A Sepharose beads (Sigma, St. Louis, MS) at 4 °C for 1 h and the beads were washed three times with RIPA buffer. Immunoprecipitates were size-fractionated on SDS-PAGE gels (6% for RyR, 10% for PDE4, 12% for PKA, PP2A, and PP1, and 15% for calstabin) and transferred onto nitrocellulose membranes for 2 h at 200 mA. Immunoblots were developed using the primary antibodies described in supplementary materials.
Endoplasmic reticulum (ER) calcium (Ca 2+ ) leak assay
The ER Ca 2+ leak assay has been previously described [17, 48] . Briefly, 50 µg/ml brain microsomes was diluted into a buffer (pH 7.2) containing 8 mM K-phosphocreatine and 2 units/ml of creatine kinase mixed with 3 µM Fluo-3. Ca 2+ loading of the microsomes was initiated by adding 1 mM ATP. After Ca 2+ uptake to saturation, 3 μM thapsigargin was added to block Ca 2+ uptake. Ca 2+ leaking out of the ER was detected as an increase in Ca 2+ fluorescence, and ryanodine (10 µM) was added to block the RyR channels and confirm that the leak was via RyR. Changes in the emission of Fluo-3 after excitation at 485 nm were measured by a fluorescence spectrophotometer (Photon Technology International, PTI) and the changes of fluorescence intensity were recorded using "FeliX version 2" software (PTI). www.stanford.edu/_cpatton/maxc.html). ER vesicles were added to the cis-side, and fusion with the lipid bilayer was induced by making the cis-side hyperosmotic by the addition of 400-500 mM KCl. After the appearance of potassium and chloride channels, the cis-side was perfused with the cis-solution. Single-channel currents were recorded at 0 mV using a Bilayer Clamp BC-525D (Warner Instruments, LLC, CT), filtered at 1 kHz using a Low-Pass Bessel Filter 8 Pole (Warner Instruments, LLC, CT), and digitized at 4 kHz. To confirm RyR identity, 5 µM ryanodine was added to the cis-side at the end of the experiments. All experiments were performed at room temperature (23 ± 2 °C). Single-channel Po was determined over 2 min of continuous recording using the method of 50% threshold analysis [16] . The recordings were analyzed using Clampfit 10.1 (Molecular Devices) and Prism (ver.5.0, GraphPad).
Single-channel data acquisition and analysis
ER vesicles containing
Electrophysiology
Electrophysiological recordings were performed by stimulating Schaeffer collateral fibers and recording in the CA1 stratum radiatum [55] . Basal responses were recorded for 30 min. Long-term depression (LTD) was induced by low-frequency stimulation (LFS) consisting of 900 pulses at 1 Hz. Responses were recorded for 120 min after LFS and measured as the slope of field-excitatory postsynaptic potential (fEPSP) and expressed as the percentage of baseline. Basal synaptic transmission (BST) was assayed by plotting the stimulating voltage (V) to fEPSP slopes to generate input-output relations. The results were expressed as mean ± standard error (SEM). One-way ANOVA was applied for data analysis.
Behavioral studies
Fear conditioning
Contextual and cued fear conditioning memories were evaluated as described previously with some modifications 1 3 [33, 42, 62] . On day 1, mice were exposed to a context of 2 min duration followed by a 85 dB tone at 2800 Hz for 30 s as a conditioning stimulus (CS), with 2 s of 0.80 mA foot shock [unconditioned stimulus (US)] at the end of the CS. Mice were taken back to the home cages 30 s after the shock. Freezing was measured immediately after the end of the shock for 30 s using the Freezeview software (MED Associates Inc.). The contextual memory (total freezing) was measured after 24 h when mice were re-exposed to the same context for 5 min (no tone, no shock). The cued fear memory was measured on day 3. Mice were placed in a novel context for 2 min (pre-CS test) followed by 3 min of tone (CS test, 85 dB tone at 2800 Hz). Freezing during the first 2 min and the last 3 min were measured separately. A digital video camera was installed inside the conditioning chamber (72 cm × 51 cm × 48 cm) and connected to Freezeframe software (MED Associates Inc.). The amount of freezing was recorded by the software as cumulative duration of the inactive state.
Other behavioral tests
Morris water maze (MWM), novel object recognition (NOR), elevated plus maze (EPM), and open field test (OF) were performed as described previously [48, 58] .
Immunohistochemistry
Aβ deposits were quantified in APP/PS1 mice in both the hippocampus and cortex regions using 6E10 primary antibody (recognizing Aβ, C99 and total APP) (Biocare Medical, CA) at 1:400 dilution with Ventana machines (Ventana Medical Systems, Inc.). Aβ plaques were counted from six slices per mouse and three mice per group. Coronal sections of paraffin-embedded brains were selected with an interval of 56 µm (each section is 8 µm) to cover the same brain regions. For astrocyte staining, we used EP672Y clone GFAP antibody with Benchmark Ultra Platform machines (Ventana Medical Systems, Inc.).
In the 3 × Tg-AD model, Aβ deposits were predominantly restricted to the hippocampus [57] and detected using 6E10 primary antibody. In this model, we used vibratome coronal brain sections (50 µm depth for each section, with an interval of 50 µm). We counted Aβ plaques from four slices per mouse, three mice per group. The analyzed sections covered the whole subiculum region. We also used: (i) APP C-terminal antibody (A8717, Sigma-Aldrich) recognizing 676-695 residues of total APP, APP C-terminal fragments (CTF:C99 and C83), and APP intracellular domain (AICD) at 1:1000 dilution, and (ii) FCA18 antibody [4] recognizing specifically the first aspartyl residue of Aβ, and C99 at 1:1000 dilution. Nuclei were detected using DAPI dye at 1:10,000 dilution. For Aβ plaques quantification, we counted extracellular senile plaques with dense Aβ core (mature plaques). We excluded low and diffuse extracellular staining.
Aβ40 and Aβ42 peptide measurements
Aβ40 and Aβ42 peptide levels from total brain (in APP/ PS1) or total hippocampal (3 × Tg-AD) lysates were measured with an ELISA kit (Wako Chemicals USA, Inc., or NOVEX™, ThermoFisher Scientific, France) using human C-terminus Aβ antibodies. The same quantity of total protein extracts was dissolved in 5 M guanidine HCl/50 mM Tris HCl, pH 8.0, to yield detection of both soluble and insoluble Aβ42 peptides.
SDS-PAGE and western blot analyses
Whole brain homogenates (50 µg) were size-fractionated on SDS-PAGE gels (4-20%) and transferred onto nitrocellulose membranes. Immunoblots were developed using the antibodies described in supplementary materials.
Measurements of spine density and diameter
Rat E18 (embryonic day 18) hippocampal neurons were isolated and cultured for 21 days before the experiment using previously established culture conditions and experimental procedures [34, 71, 76] . Briefly, 100,000 cells were plated per 60-mm dish. Dendritic spine number was calculated in individual mature hippocampal neurons obtained from three independent experiments (n = 9 cells/treatment within one experiment). Neurons were exposed to synthetic Aβ42 (200 nM) for 24 h with or without S107 (1 or 10 µM). Mature hippocampal neurons were stained with TRITCconjugated phalloidin revealing actin-rich structures along the dendritic shaft [71] . We analyzed a total dendrite length of 40 μm per cell. Dendritic spine number and diameter were determined based on the phalloidin staining obtained from a 2D projection (maximum intensity) of each image stack [75] . The diameter and density of dendritic spines per cell were averaged from each experiment (total population in each experiment). Data from the three experiments were pooled together and plotted.
Statistical analyses
All experimental mice were coded to blind investigators with respect to genotypes and S107 treatment. MWM and LTP/LTD results were revealed by two-way ANOVA and post-test comparisons. Other studies that contained multiple groups were revealed by one-way ANOVA and Bonferroni post-test or Tukey multiple comparison test. Results were expressed as mean ± SEM. Sample size for each experiment is stated in the figure legends. Minimum statistically significant differences were established at p < 0.05.
Results
RyR2 macromolecular complex is remodeled in human Alzheimer's brains and in AD-like murine models
Neuronal RyR2 channels were examined for evidence of post-translational modifications consistent with the biochemical signature of leaky RyR2 channels [51, 52] . Neuronal RyR2 from age-matched "control" brains (diagnosed as negative for any neuropathology) (suppl. Table I ) had no biochemical remodeling of the RyR2 macromolecular complex, while the age-matched "non-AD" brains (negative for any AD-related neuropathology, i.e., absence of neurofibrillary tangles and neuritic plaques) (suppl. Table I ) exhibited nitrosylation and oxidation of RyR2 with partial calstabin2 depletion, but no PKA phosphorylation. Only the AD patients (suppl. Table I ) exhibited RyR2 PKA hyperphosphorylation (at Ser2808), in addition to oxidation (DNP), nitrosylation (Cys NO) and nearly complete channel stabilizing subunit calstabin2 (FKBP12.6) depletion (Fig. 1a-e) . Intriguingly, RyR2 macromolecular complexes from the AD patients also showed reduced serine/threonine protein phosphatase 1 (PP1) [51, 52] and reduced anchoring protein spinophilin [51] (Fig. 1a, f, g ). PKA, PDE4 and PP2A expression remained unchanged in AD brains as compared to controls and non-AD brains (Fig. 1a , and Suppl. Figure 1a -c). RyR2 channels were PKA phosphorylated, oxidized, nitrosylated and depleted of calstabin2 in both the double transgenic AD mouse model (APP [22, 38] (Fig. 1h-l ) and the triple transgenic AD mouse model (3 × Tg-AD: APPswe, PS1-M146V, and Tau-P301L) [57] (Fig. 1o-s) . In these AD-like mice models, PP1 and spinophilin were also depleted from the RyR2 macromolecular complex (Fig. 1h , m-o, t, u), while PKA, PDE4 and PP2A levels remained unchanged (Fig. 1h , o and Suppl. Figure 1d -i). We used the RyR-targeted small molecule Rycal S107 that stabilizes binding of calstabin to RyR2 and thereby stabilizes the closed states of PKA phosphorylated and oxidized/nitrosylated channels by preventing calstabin2 depletion [51, 52] . Administration of S107 to APP +/− /PS1 +/− and 3 × Tg-AD mice had no effect on PKA hyperphosphorylation or oxidation/nitrosylation of RyR2, but significantly increased the amount of calstabin2 in the RyR2 channel complex (Fig. 1h, l, o, s) . RyR2 channels from 3-month-old APP +/− /PS1 +/− mice crossed with the RyR2-S2808A +/+ knock-in mice, harboring RyR2 channels that cannot be PKA phosphorylated [48] , did not undergo phosphorylation but exhibited reduced oxidation and nitrosylation and there was no evidence of calstabin2 depletion from the RyR2 complex (Fig. 1h-l) .
RyR2-S2808A
+/+ × APP +/− /PS1 +/− crossed mice showed increased amounts of PP1 and spinophilin in the channel complex as compared to APP +/− /PS1 +/− mice (Fig. 1h , m, n).
There were no changes in total RyR2 or calstabin2 levels in the whole brain lysates from all experimental animals as previously reported [48] . S107 does not affect the levels of RyR2 or calstabin2 in WT mice. The remodeling of RyR2 observed in the brains of AD patients and of ADlike mice models represents the "biochemical signature" of leaky channels.
RyR2 is PKA phosphorylated through the activation of the β-adrenergic receptor (β-AR) signaling cascade [51, 52] . Interestingly, PKA activity was increased in APP +/− / PS1 +/− (Suppl. Figure 2a) , suggesting the contribution of β-adrenergic signaling cascade in these mice. Mitochondrial ROS production was also enhanced in APP +/− / PS1 +/− mice and inhibited by S107 or by crossing APP +/− / PS1 +/− with RyR2-S2808A +/+ mice (Suppl. Figure 2b ). Taken together, these data suggest that RyR2 remodeling is likely triggered by synergistic oxidative and β-adrenergic stimulation.
Remodeling of neuronal RyR2 channel complexes results in abnormal Ca 2+ homeostasis
We then asked whether the remodeling of neuronal RyR2 channel complexes results in abnormal Ca 2+ homeostasis. Neuronal microsomes from APP
+/− mice exhibited increased ER Ca 2+ leak compared to WT mice (Fig. 2a, b ). Pharmacologically stabilizing calstabin2 on RyR2 complex by administering S107 or genetically crossing with RyR2-S2808A +/+ mice significantly reduced neuronal ER Ca (Fig. 2a, b) . Addition of the specific RyR blocker ryanodine (10 µM) after thapsigargin-triggered Ca 2+ leak abolished the leak (Suppl. Figure 3a-d) , thus confirming the RyR channel as the trigger of the Ca 2+ leak. Consistently, hippocampal RyR2 channels from 3 × Tg-AD mice were leaky as manifested by increased single-channel open probabilities (Po) (Fig. 2c, d ). Treatment of the 3 × Tg-AD mice with the S107 normalized the channel Po consistent with fixing the leak (Fig. 2c, d) the ER in neurons) activity was increased in APP
+/− mice compared to WT, but treatment with S107 did not affect SERCA activity (Suppl. Figure 4a ). Caffeine-induced ER Ca 2+ release was increased in APP
+/− mice compared to the control, and S107 reduced this response (Suppl. Figure 4b-e) . This increased sensitivity of RyR channels to caffeine in the APP
mice is likely due to depletion of calstabin2 from the channel complex, which destabilizes the closed state of RyR channels and sensitizes the channel to caffeine [9, 52] . Ca 2+ influx through voltage-gated calcium channels (VGCC) was normal in APP
+/− mice and unaffected by S107 treatment (Suppl. 
/PS1
+/− and control neurons, and unaffected by S107 treatment (Suppl. Figure 4j) . Table I ) "control" (n = 3); age-matched "non-AD" individuals (n = 4); and Alzheimer's patients (AD) (n = 6); h-n WT, APP +/− /PS1
+/− crossed mice (n = 4 for each group of mice); o-u WT, 3 × Tg-AD and 3 × Tg-AD + S107 mice (n = 5 for each group of mice) immunoblotted for total RyR2, RyR2-pS2808 (RyR2 PKA phosphorylation site), S-nitrosylation (CysNO), oxidation (DNP), as well as components of the RyR2 channel complex including: PKA catalytic subunit (PKA), phosphodiesterase 4D3 (PDE4), protein phosphatase 2A (PP2A), protein phosphatase 1 (PP1) and its anchoring protein spinophilin and calstabin2. S107 treatment was from 4 weeks of age until testing at 3 months in APP
, and from 11 months of age for 4 weeks in 3 × Tg-AD mice. Graphs represent mean ± SEM. *p < 0.05 calculated versus control using one-way ANOVA and Tukey's post-tests Previous studies in FAD mice have shown that RyRmediated ER Ca 2+ release can facilitate glutamatergic spontaneous excitatory postsynaptic potential (sEPSP) activity [8, 11, 35] . APP +/−
+/− CA1 pyramidal neurons exhibited significantly increased sEPSPs frequency compared to WT mice, consistent with intracellular Ca 
Impaired RyR2 function affects cognitive behavior in AD-like mice models
We next sought to determine whether leaky hippocampal RyR2 channels modulate the encoding or retrieval of contextual fear memories. In the contextual fear conditioning (FC) test, 3-month-old APP +/− /PS1 +/− mice exhibited decreased freezing compared to the WT mice (Fig. 3a) . This was improved when RyR2-mediated intracellular Ca 2+ leak was inhibited either pharmacologically with S107 treatment of APP +/− /PS1 +/− mice, or genetically in RyR2-S2808A +/+ × APP +/− /PS1 +/− crossed mice (Fig. 3a) . There was also decreased freezing in auditory cued FC in APP +/− /PS1 +/− compared to the WT mice (Fig. 3b) , which was improved by genetic rescue (crossing APP +/− /PS1 +/− mice with RyR2-S2808A mice), but not by S107 treatment. These data suggest that the intracellular Ca 2+ leak via remodeled RyR2 channels may be associated with impaired encoding and retrieval of contextual fear memory. APP
+/− mice also exhibited short-term memory deficits as manifested in the novel object recognition (NOR) test by reduced discrimination index (DI) between the novel object and the constant object after 1 h (Fig. 3c,  d ). Both pharmacologic treatment with S107 and genetic rescue improved hippocampal-based short-term memory as evidenced by normalization of the DI (Fig. 3d) . These data further suggest that RyR2 Ca 2+ leak is associated with impaired short-term memory formation in a murine model of AD.
We assessed the effects of leaky RyR2 channels on spatial learning and memory using the Morris water maze ] c , control Po = 0.0145 ± 0.0044, n = 5 vs. 3 × Tg-AD Po = 0.1304 ± 0.0313, n = 6). Treatment of the 3 × Tg-AD mice with the S107 (as in Fig. 1o-u) normalized the channel Po (Po = 0.0275 ± 0.0249, n = 6) consistent with fixing the leak. Data are mean ± SEM. *, p < 0.05 versus WT. Data were analyzed using the one-way ANOVA and Tukey's post-test in all quadrants and the number of target crossings on day 6 probe trial of the MWM. h Swimming speeds were recorded on day 6 probe trial. i Escape latencies for the visible platform test was performed for 2 days after day 6 of the probe trial, 3 trials per day, 60 s for each trial. j Ratio of the center vs. periphery visits in the open field test (OF). k Time spent in the open vs. closed arms of the elevated plus maze (EPM) and l the ratio of the number of entries to the open vs. closed arms. The same groups of mice were used for NOR, MWM, OF and EPM tests. Separate groups of naïve mice were used for FC tests. S107 treatment was from 4 weeks of age until testing at 3 months. Learning curve data from MWM test were analyzed using the two-way ANOVA. All other data were analyzed using the one-way ANOVA and Bonferroni post-test. Graphs show mean ± SEM, *, p < 0.05 versus WT mice, #, p < 0.05 versus APP
/PS1 +/− mice exhibited higher escape latencies in the MWM (Fig. 3e) , spent less time in the target quadrant and had a reduced number of target crossings compared to WT mice (Fig. 3f, g ). S107 treatment of APP +/−
/PS1
+/− mice partially improved the escape latency, the time spent in the target quadrant and the number of target crossings compared to untreated APP
+/− mice. Genetic rescue of leaky RyR2 channels using RyR2-S2808A +/+ × APP +/− /PS1 +/− crossed mice resulted in normalization of escape latencies (Fig. 3e) , the time spent in the target quadrant and the number of target crossings (Fig. 3f, g ). Similar data were obtained using the 3 × Tg-AD model in the MWM showing that S107 treatment improved the escape latency (Suppl. Figure 5a ). In the probe trials, S107-treated 3 × Tg-AD mice exhibited reduced latency to the first entry into the target quadrant (TQ) and platform (PF) zones (Suppl. Figure 5b , and 5c) and reduced distance to the first entry in the PF zone (Suppl. Figure 5d) . Accordingly, S107-treated 3 × Tg-AD mice spent more time and showed enhanced number of entries in TQ zone (Suppl. Figure 5e , and 5f). Importantly, the observed deficits in the MWM in both APP
+/− and 3 × Tg-AD mice models were not due to defects in swimming speed (Fig. 3h , and Suppl. Figure 5 g ) or altered vision function (Fig. 3i) .
Leaky RyR2 channels were associated with additional behavioral abnormalities including increased anxiety studied by open field (O-F) and elevated plus maze (EPM) tests. The APP +/−
+/− mice made an equal number of visits to the center and periphery in the O-F test (Fig. 3j) and spent more time and made more entries into the open arms of the EPM (Fig. 3k, l) , in agreement with disinhibited behavior previously reported in APP +/−
+/− mice [40] . This behavior was restored to normal by both pharmacologic treatment with S107 and genetic rescue with RyR2-S2808A +/+ × APP +/− /PS1 +/− crossed mice (Fig. 3j-l) . Additionally, APP +/−
+/− mice exhibited increased spontaneous exploratory behavior that was not seen in mice treated with S107 or in RyR2-S2808A +/+ × APP
+/− crossed mice in the NOR, OF and EPM tests (Fig. 3c, j, k) .
RyR2 leak impairs postsynaptic function in hippocampal neurons
As part of the "Ca 2+ hypothesis" of AD, it has been proposed that a combination of progressive reduction in longterm synaptic potentiation (LTP) and increase in long-term synaptic depression (LTD) may contribute to memory loss [6, 25, 55] . CA3-CA1 Schaffer collateral LTP was reduced in 3-month-old APP +/−
/PS1
+/− mice compared to WT (Fig. 4a ) with no differences in basal synaptic transmission (BST) (Fig. 4c) . Both pharmacologic treatment with S107 and genetic rescue in 
+/− mice (Fig. 4a) . LTD was also reduced in 3-month-old APP +/−
+/− mice compared to WT and restored to the WT levels by treatment with S107 or with genetic rescue (Fig. 4b) . LTP and LTD were also reduced in 6-month-old APP +/−
+/− mice with reduced BST as well (Fig. 4d-f) . Treatment with S107 improved both LTP and LTD at 6 months of age (Fig. 4d-f ). S107 treatment had no effect on LTP, LTD or BST in WT mice (Suppl. Figure 6c -e). These data suggest that both defective memory formation (LTP) and impaired editing (LTD) contribute to cognitive and behavioral abnormalities observed in APP
+/− mice that are rescued by pharmacologic or genetic targeting of RyR2 leak.
Loss of postsynaptic dendritic spines contributes to memory and cognitive deficits in AD [53, 75, 76] . We examined the possible effects of leaky RyR2 channels on dendritic spine morphology by treating primary cultured hippocampal neurons with S107 in the presence of Aβ42 peptides. The spine diameter was significantly decreased 24 h after the addition of Aβ42 peptides (200 nM) (Fig. 4g) . Pretreatment with S107 prevented dendritic spine collapse (Fig. 4g) .
Leaky RyR2 channels contribute to neuropathology in transgenic AD-like mice
Next, we determined whether inhibiting leaky RyR2 affects Aβ plaque deposition in brain slices in 5-monthold APP +/−
/PS1
+/− mice. Both S107 treatment (beginning at 3 months of age) and genetic rescue with RyR2-S2808A +/+ × APP +/− /PS1 +/− crossed mice reduced the number of Aβ plaques (Fig. 5a-e) . Accordingly, treatment of 3 × Tg-AD mice at 11 months of age (a point at which Aβ plaques begin to be detectable in this model) with S107 for 4 weeks also reduced the number and size of Aβ plaques ( Fig. 5f-j) . GFAP staining revealed increased astrogliosis in the hippocampal CA1 area in APP +/−
+/− brain slices that was also reduced by S107 treatment and genetic rescue in RyR2-S2808A +/+ × APP Figure 7a-h ). The total APP was increased in the hippocampus of the 3 × Tg-AD mouse model (due to βAPP transgene overexpression) (Fig. 5k, l) . Interestingly, the levels of C83 and C99 (α-CTF and β-CTF, respectively), two fragments resulting from βAPP cleavage by α-secretase and β-secretase (BACE1), were reduced by S107 treatment (Fig. 5k, l) .
We previously reported that 3 × Tg-AD mice show a concomitant accumulation of both C99 and C83 and that increased C83 levels derived from α-secretase mediated the cleavage of C99 [27, 41, 58] . Therefore, the reduced production of C83 observed in S107-treated animals could likely be accounted for by reduced levels of its precursor C99. C99 also undergoes cleavage by γ-secretase to yield Aβ40 and Aβ42 peptides. The total amounts of soluble and insoluble Aβ40 and Aβ42 were significantly reduced by S107 treatment in both 3 × Tg-AD and APP (Fig. 5k, m, n) and in RyR2-S2808A +/+ × APP
+/− crossed mice (Fig. 5n) . These findings were further confirmed in 3 × Tg-AD mice by immunohistochemistry using anti-C-terminus antibodies that specifically recognize α-CTF and β-CTF (Suppl. Figure 7i-k) , or with FCA18 antibody [4] that interacts specifically with the N-terminal aspartyl residue common in both the Aβ and C99 fragments (Suppl. Figure 7i-n) .
BACE1 is highly expressed in neurons and its expression increases during aging as well as in the brains of AD patients [88] . It was also reported that there is a positive correlation between elevated BACE1 activity, increased Aβ levels and plaque load in mouse and human brain regions [45, 88] . Accordingly, we showed that BACE1 and βCTF levels were increased in human AD brains (Suppl. 
+/− brains (Suppl. Figure 8b) . 
+/− + S107, 11 slices from six animals; RyR2-S2808A
, 11 slices from six animals. Data were analyzed by two-way ANOVA. S107 treatment was from 4 weeks of age until age of testing (3 or 6 months). g Spine diameter was measured in cultured murine hippocampal neurons. Exposure to Aβ42 (200 nM) for 24 h reduced spine diameter and treatment with S107 prevented the reduction in spine diameter. Data were analyzed using the one-way ANOVA and Bonferroni post-test, Graph shows mean ± SEM *, p < 0.05 vs. control (no Aβ), or vs. Aβ treated neurons 
+/− mice treated with S107 beginning at 4 weeks for 4 months (testing at 5 months old), and d RyR2-S2808A +/+ × APP +/− /PS1 +/− crossed mice. e Summary data of the number of plaques (mean ± SEM). Data were taken from six slices per mouse, three mice per group. *, p < 0.05 vs. WT mice, or vs. APP/PS1 mice. f-h Amyloid β plaque depositions (Green signal) in WT (f), 3 × Tg-AD mice (11 months old) treated (h) or not (g) for 4 weeks with S107 (testing at 12 months). Data were taken from four slices per mouse, three mice per group. i, j Graphs show mean ± SEM of the number (i) and area (j) of Aβ plaques *, p < 0.05 vs. WT mice, or vs. 3 × Tg-AD mice. k Representative blots showing the expression of full length βAPP, C83 (α-CTF) and C99 (β-CTF), and Aβ in the hippocampus of WT, 3 × Tg-AD and 3 × Tg-AD + S107 mice. Data were taken from >6 animals per group. l The graph shows mean ± SEM of protein levels calculated versus 3 × Tg-AD mice considered as 100%. *, p < 0.05 versus 3 × Tg-AD mice. m, n Soluble and insoluble Aβ40 and Aβ42 levels (detected in total brain lysates (in APP/PS1), or in total hippocampal (3 × Tg-AD) lysates). Data were taken from >4 animals per group. Figure 8b) .
We also examined the consequences of inhibiting RyR2-mediated ER Ca 2+ leak on the regulation of additional signaling proteins that have been implicated in AD (Suppl. Figure 8 ). In addition to BACE1 and βCTF, pAMPK, Cdk5 truncated activator p25, phosphorylated tau (pT181, pS262) and sAPPβ were increased in human AD brains (Suppl. Figure 8a ) as well as in APP
+/− brains (Suppl . Figure 8b) . S107 treatment and genetic rescue returned the levels of these signaling proteins to normal (Suppl. Figure 8b) . The formation of neurofibrillary tangles is reported to be downstream of the Ca 2+ -dependent protease calpain [69] . Tissue calpain activity was increased ~sixfold compared to WT mice in APP
+/− brains (Suppl. Figure 8c ) and was reduced by both S107 treatment and genetic rescue with RyR2-S2808A +/+ × APP Figure 8c ).
Constitutive RyR2 phosphorylation induces synaptic and cognitive deficits
We then explored the importance of RyR2 PKA phosphorylation and leak in synaptic and cognitive deficits in a genetic background free of any AD-associated mutations using a PKA phosphomimetic knock-in mouse model (RyR2-S2808D +/+ ) [48, 72] . At 3 months of age, hippocampal RyR2 channels from RyR2-S2808D +/+ mice were oxidized, nitrosylated and depleted of calstabin2 (Fig. 6a) . S107 treatment prevented calstabin2 depletion from hippocampal RyR2 channels (Fig. 6a) , but had no effect on channel oxidation and nitrosylation in RyR2-S2808D +/+ mice. Neuronal microsomes isolated from RyR2-S2808D +/+ mice brain exhibited increased ER Ca 2+ leak compared to those from WT mice (Suppl. Figure 9a , 9b). Administration of S107 significantly reduced neuronal ER Ca 2+ leak in RyR2-S2808D +/+ mice (Suppl. Figure 9a , 9b). Adding ryanodine confirmed that the source of Ca 2+ release was mainly associated with RyR channels (Suppl. Figure 3e, 3f) . Thus, phosphomimetic neuronal RyR2 channels in RyR2-S2808D +/+ mice cause an ER Ca 2+ leak.
RyR2-S2808D
+/+ mice exhibited also cognitive and behavioral dysfunctions as assessed by contextual and cued FC (Fig. 6b, c) , MWM (Fig. 6d-f) , NOR (Fig. 6j) , and EPM tests (Fig. 6k, l) , without differences in swimming or latency to find a visible platform (Fig. 6g, h ). Accordingly, LTP and LTD were reduced and synaptic strength was decreased in 3-month-old RyR2-S2808D +/+ mice (Fig. 6m-o) , consistent with a reduction in dendritic spine density in the hippocampal neurons in RyR2-S2808D +/+ mice and a decrease in postsynaptic density protein-95 (PSD95) expression [64, 80] (Fig. 6p, q) . S107 treatment of RyR2-S2808D +/+ mice beginning at 4 weeks of age until testing at 3 months of age (S2808D + S107 (F0)) failed to improve learning and memory deficits (Fig. 6b-l) . Interestingly, continuous oral S107 treatment for two generations (F2) improved cognitive deficits (Fig. 6b-l) and restored LTP, LTD and BST of RyR2-S2808D +/+ in 3-month-old mice (Fig. 6m-o) . Normalization of these defects by fixing leaky RyR2 with S107 over two generations suggests an epigenetic effect, some of which has been reported in AD [29] . Interestingly, we found that methylation of hippocampal DNA was increased in RyR2-S2808D +/+ mice compared to WT mice. S107 treatment decreased DNA methylation in the F2 generation, but not in F0 or F1 generations (Suppl. Figure 10 ). These data suggest that chronic RyR-mediated ER Ca 2+ leak may exert an epigenetic effect regulating gene expression associated with cognitive deficits and synaptic alteration.
Discussion
It has been proposed that defects in Ca 2+ signaling could account for many aspects of AD including memory loss [6] , and Ca 2+ channels have been recognized as triggering cell survival or death [50] . Indeed, genes encoding Ca 2+ handling proteins have recently been linked to AD in human genome studies [36] . Altered Ca 2+ regulation has been reported in both sporadic forms of AD, and FAD linked to βAPP and PS1/2 mutations [13, 58] . Moreover, alterations of the expression and function of RyR channels have been reported in human brains and AD models [14, 77, 78] . Several studies have showed that PS mutations induce exacerbated IP 3 R-and RyR-mediated Ca 2+ release [15, 24, 44, 77, 78] . It was proposed that the enhanced RyR-mediated ER Ca 2+ release is likely associated with impairment of PS-mediated Ca 2+ leak function and to increased ER Ca 2+ pool [92] . However, experiments using the PS1/2 conditional double knockout mice lead to controversial conclusions [87, 92] . Importantly, the impact of Aβ and of βAPP overexpression on RyR dysfunction was revealed independently of PS mutation or overexpression [43, 56, 58, 79] . Of most interest, it was also reported that exogenous Aβ oligomers may stimulate RyR-mediated Ca 2+ release in wild-type hippocampal neurons [61] .
We show now that the "biochemical signature" of leaky RyR2 channels is present in the brains of patients with sporadic AD as well as in two murine models harboring FADrelated mutations, suggesting that leaky RyR2 channels may be relevant to both familial and sporadic forms of AD. (S2808D), and S107 treated RyR2-S2808D +/+ (S2808D + S107) mice brains as in Fig. 1. S2808D +/+ mice were treated orally with S107 from 4 weeks until testing at 2 months. Data are mean ± SEM. *p < 0.05, n = 4 for each group. Freezing responses in contextual FC (b) and auditory cued FC (c). WT, n = 13, RyR2-S2808D +/+ , n = 15, S2808D + S107(F0), n = 10, S2808D + S107(F2), n = 13. S2808D +/+ mice were treated as in (a) (F0), or continuously for two generations (F2). d Learning curves showing the escape latency for mice to reach the hidden platform during 5-day trials. e, f Probe trials showing the time spent in the target quadrant (e) and the total number of target crossings (f) for the mice. Two-way ANOVA was used to analyze the learning curves, one-way ANOVA was used to analyze the probe trial tests. WT, n = 15, S2808D, n = 18, S2808D + S107(F0), n = 18, S2808D + S107(F2), n = 14. g Swimming speeds were recorded on day 6 of the probe trial. Data are mean ± SEM. h Escape latencies are shown for the visible platform test was performed as in Fig. 3 . i Novel object recognition (NOR) test: exploration duration for two identical objects. j Discrimination index after 1-h interval. Data are presented as mean ± SEM. k, l EPM test, ratios of time spent in the open arm and closed arm and total number of entries. Data are presented as mean ± SEM. m-o Electrophysiological LTP (m), LTD (n), and fEPSP slope (o) recordings were performed as in Fig. 4 . Two-way ANOVA was used for data analyses. WT, n = 14 slices were from nine mice, S2808D, n = 7 slices from seven mice, S2808D + S107 (F0), n = 6 slices from six mice, S2808D + S107(F2), n = 9 slices from four mice. p Representative image and summary graph of spine density. Spine images were taken from six mice in each genotype. Data were taken from 10 to 20 neurons/mouse. Data were analyzed as mean ± SEM, *p < 0.05 versus WT mice. Scale bar: 1 µm. q Expression of PSD95 in hippocampal samples from the WT (WT) and RyR2-S2808D +/+ (S2808D) (n = 3) mice were examined by immunoblot analysis. Total ERK1/2 at 42 and 44 kDa served as loading control. Data were analyzed as mean ± SEM, *p < 0.05, vs. WT mice. j-q data were analyzed using the one-way ANOVA and Tukey's post-test β2-Adrenergic receptors (β2-ARs) have been implicated in the development of AD [90] . Interestingly, β2-AR gene variants have been identified as risk factors for lateonset AD [89] . Oxidative stress is also a major contributor to AD pathogenesis [31, 37, 83] . We suggest that RyR2 remodeling likely occurs through synergistic oxidative and β-adrenergic stimulation. It has already been shown that Aβ stimulates PKA activity and PKA-dependent signaling pathways by activating β-ARs [23, 39, 59, 66] . Conversely, β-ARs blockers and inhibitors of PKA diminish Aβ production and delay functional decline in AD [49, 68] . However, the mechanism underlying this functional interplay remains uncertain. Activation of β2-ARs enhances γ-secretase activity and accelerates Aβ plaques formation [54, 90] , a process that can be blocked by the specific β2 antagonist [90] . Interestingly, Aβ42 peptide binds to the N-terminus of β2-ARs [84] .
We show in the present study that neuronal RyR2 channels are PKA phosphorylated in both human AD patients and in two murine models of AD. Preventing PKA phosphorylation of RyR in RyR2-S2808A
+/− crossed mice provides strong support for the potential role of the adrenergic signaling cascade in the pathogenesis of AD. Indeed, in the human samples, a major difference in RyR2 biochemistry between non-AD and AD patient samples is PKA phosphorylation of the RyR2 channel. We noticed the presence of phosphorylated tau (pTau181, and pTau262) in age-matched AD human controls. Indeed, it was previously reported that abnormally phosphorylated tau accumulates as neurofibrillary tangles and neuropil threads in older persons with and without AD [18] .
In accordance with our study, the beneficial effects of genetic knockdown or pharmacologic blockade of β2-AR were reported in tau [86] and in Tg2576 transgenic mice [21] . Selective targeting of β-AR to reverse/prevent AD pathology remains, however, controversial. The administration of a β2-AR antagonist has been shown to exacerbate neuropathology and cognitive deficits in a mouse model of AD [7] . The pharmacological stimulation of β2-AR has been shown to improve cognitive function and restore synaptic density in a mouse model of Down syndrome [19] . Recently it has also been reported that an enriched environment activates β2-ARs and protects against Aβ-induced reduction in LTP and prevents Aβ oligomers-mediated hippocampal impairment [46] . Importantly, while it is well established that β-adrenergic signaling is important for learning and memory, it appears that chronic activation of this cascade may be detrimental.
Intracellular Ca 2+ release via RyRs has been proposed to be involved in the regulation of LTD and LTP which represents the cellular basis for learning and memory [1, 25, 67, 82] . A previous study reported that inhibition of RyR channels enhances hippocampal LTD [12] . This finding is consistent with our present data showing reduced LTD in the presence of leaky RyR2 channels. In mice with impaired LTD, Kandel and colleagues reported downregulation of RyRs and up-regulation of inhibitor 1 which inhibits PP1 [25] . Inhibition of PP1 would promote PKA phosphorylation of RyR2 as we found in both human AD and murine AD models. We show that in AD human brains and in AD-like mice models, the RyR2 macromolecular complex is depleted of both PP1 and its anchoring protein spinophilin [2, 26] . This is consistent with the fact that the amount of spinophilin is decreased in the AD brain [59] . Here, we show for the first time, in an adult AD mouse model that LTD (memory editing) is reduced, suggesting that a combination of impaired storage of new memories (decreased LTP) combined with reduced memory editing (decreased LTD) contributes to decreased memory flexibility [55] and increased confusion in AD.
It has been reported that Ca 2+ plays a role in the production of Aβ peptides, tau phosphorylation and neurofibrillary tangles in AD [20] . We show that signaling pathways leading to Aβ production and tau phosphorylation are activated in the setting of chronic intracellular Ca 2+ leak. Moreover, pharmacologic and genetic fixing RyR2-mediated Ca 2+ leak decreased the activation of these signaling pathways leading to reduced Aβ production and tau phosphorylation. In support of these findings, the RyR active drug dantrolene has been shown to prevent AD-type pathology [91] , including a reduction in Aβ plaques, in some [11, 58, 63] , but not all studies [92] . However, the application of dantrolene in clinic for the treatment of AD is questionable due to adverse side effects associated with its chronic use [47] .
Another key finding in the present study is that the expression of a phosphomimetic RyR2-S2808D +/+ channel in mice results in neuronal intracellular Ca 2+ leak associated with cognitive and behavioral deficits. Interestingly, the finding that it takes two generations of fixing RyR2-mediated ER Ca 2+ leak (with S107) to show improvement in the AD-like phenotype and the reduction in methylation of hippocampal DNA in the RyR2-S2808D +/+ mice points toward a potentially strong contribution of ER Ca 2+ leak physiology to epigenetic control [5, 30] .
An important question is what is the initiating event in AD? Do leaky RyR2 channels activate a signaling cascade resulting in Aβ plaque deposition and tangle formation that cause AD, or does Aβ activate RyR2 channels [60] causing an intracellular Ca 2+ leak that leads to further pathology? We suggest that an increase in the formation of Aβ peptides in FAD could lead to Aβ-dependent β-adrenergic and oxidative stress. Yet, an age-dependent increase in oxidative stress could also play a role in the disease mechanism of SAD. The finding of leaky RyR2 channels due to post-translational modifications by oxidation and PKA phosphorylation supports the hypothesis that intracellular Ca 2+ leak can be an initiating or early factor in the development of AD, particularly in individuals with an underlying predisposition to AD. The age-dependent component of sporadic AD is consistent with the age-dependent ER Ca 2+ leak in RyR channels that occurs due to progressive oxidative stress [3] . Data from the present study and from others [11, 58, 63] showing that RyR-mediated Ca 2+ release is upstream of Aβ plaque formation, combined with data suggesting that Aβ can activate RyR channels [60] , raise the possibility of a vicious cycle in which leaky RyR2 channels promote Aβ production and Aβ enhances RyR2 leak (Fig. 7) . Fig. 7 The vicious cycle of Alzheimer's disease neurodegeneration involving Aβ, β2-adrenergic signaling, and leaky RyR2 channels. ER Ca 2+ leak via phosphorylated and oxidized RyR2 channels resulting from synergistic Aβ-dependent β2-adrenergic (Box A) and oxidative/nitrosative stress (Box B) accelerate the neuropathology associated with AD, forming a vicious cycle in which Aβ activates adrenergic and oxidative signaling that promotes ER Ca 2+ leak via RyR2. This in turn exacerbates Aβ production (Box C). Breaking the cycle using S107 to fix the leaky RyR2 channels slows down the AD disease process, reduces neuropathology and improves cognitive function in AD 
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